Yarger Wealth Strategies LLC Invests $242,000 in Cardinal Health, Inc. (NYSE:CAH)

Yarger Wealth Strategies LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,759 shares of the company's stock, valued at approximately $242,000.

Other large investors have also modified their holdings of the company. Cyrus J. Lawrence LLC bought a new position in Cardinal Health in the fourth quarter worth about $26,000. Promus Capital LLC bought a new position in Cardinal Health in the fourth quarter worth about $30,000. Bellwether Advisors LLC bought a new position in Cardinal Health in the fourth quarter worth about $32,000. Tompkins Financial Corp raised its holdings in shares of Cardinal Health by 106.7% during the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after buying an additional 128 shares during the last quarter. Finally, Lee Danner & Bass Inc. bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $35,000. Institutional investors own 87.17% of the company's stock.

Cardinal Health Trading Up 4.5%

CAH traded up $6.90 during trading on Thursday, hitting $160.43. The stock had a trading volume of 2,968,015 shares, compared to its average volume of 2,225,422. The firm has a market cap of $38.29 billion, a PE ratio of 29.93, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $161.12. The company has a 50 day simple moving average of $144.62 and a 200-day simple moving average of $132.08.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.20. The company had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The business's revenue was up .0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.08 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.27%. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's dividend payout ratio is presently 31.83%.

Analyst Ratings Changes

A number of research firms have recently weighed in on CAH. Mizuho lifted their price target on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a report on Monday, March 31st. UBS Group lifted their price target on Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a report on Tuesday, April 29th. Wells Fargo & Company raised Cardinal Health from an "equal weight" rating to an "overweight" rating and lifted their price target for the company from $136.00 to $179.00 in a report on Tuesday, June 3rd. Evercore ISI raised their price objective on shares of Cardinal Health from $175.00 to $180.00 and gave the company an "outperform" rating in a research note on Thursday. Finally, Bank of America raised their price objective on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $153.43.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.